Every SEC Form 3/4/5 on record for this filer (CIK 1921163) — 1 issuer, 34 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | Chief Financial Officer | 2022-04-19 → 2026-04-21 | 19 | −$10M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PTGX | 2026-04-20 | Sell | 1,750 | $105.47 | $184,573 | 59,003 |
| PTGX | 2026-03-26 | Sell | 24,765 | $104.24 | $3M | 60,753 |
| PTGX | 2026-01-27 | Sell | 18,203 | $83.14 | $2M | 60,320 |
| PTGX | 2026-01-27 | Sell | 28,000 | $83.13 | $2M | 78,523 |
| PTGX | 2026-01-20 | Sell | 8,588 | $82.48 | $708,338 | 78,077 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.